Member Info for LTbeliever

David,

I agree, the SP is kept low because of the shocking events of last year and also, the lack of hard numbers in the recent RNSs.

Hopefully, the next ones will have some numbers for the Market to digest.

Good luck to you too, Iceman.

David, I partly agree with the no details part, but remember these new technologies are highly confidential and have to remain so, for Unilever to get a first-mover advantage; this has been already a 2-year project, with more to come obviously and Unilever would not partner with APTA if they had doubts about the long-term; also remember that the Co mentioned a few weeks ago about 6-8mn of medium term deals for potential closing, this could be one of them; the other being - possibly (just MO) - the top5 pharma partner for the IHC collaboration via Optimer + platform (more news maybe on Wednesday).

Iceman, nobody can time the market; just buy small lots every month and you will not get caught out.

The SP is near all time lows and there is plenty of newsflow to come in the next few months.

Iceman,

Pls read the RNSs; the Co announced end of January they had 2.1 mln cash; and in their November presentation, they specified a monthly cash burn of 285k.

Assuming you are not a shorter, the Co had 2.1 mln at end of January, with a monthly cash burn of 285k i.e. 7 months hence, taking us to August 2024; in addition, gross income from H124 Sales (between 1.5-2.5) gives it another 700-1.3mln, so extra 3-5 months; and this ignores any income from Jan-to-June 2024, or to Dec.2024 when the definite cash could possibly run out.

Iceman,

Can u pls enlighten the rest of us? You ask how much cash is left, whilst saying with a lot of certainty "hate to buy JUST before placing"...so, where have you based this assertion?

If no RNSs were forthcoming, you'd probably say, "no news, no activity, a placing is imminent"?

If RNSs come, you say "these companies send out news to pump the price before a big placing"

So I guess, you can't lose, can you?

This will be huge, IMO, as more Unilever-like companies will get interested (and become APTA clients hopefully).

And we still have Wednesday to look out for!

Otherwise, why specify an exact time, 2 hours after mkt open on the 13th, for a simple presentation?

"A pre-recorded webcast from Dr David Bunka, Chief Scientific Officer of Aptamer Group, reviewing the Optimer®+ platform and the technical progress to date, will be available on the Aptamer Group website from 10:00am (UCT) on 13 March, 2024, at: https://aptamergroup.com/investors/reports-and-presentations/."

Unless I am missing something?

From previous RNSs: July 2022 -- Contracts signed with a top five pharmaceutical company to develop multiple Optimer® binders as immunohistochemistry (IHC) reagents to support pipeline development and early discovery targets; March 2023-- Optimer®-Fc tools launched to enable immunohistochemistry research and diagnostic workflows; Aug. 23--Signed two deals with a top five pharma partner, valued at up to £0.2 million for the development of tools for use in immunoassays and IHC in detecting neuronal targets; "The first contract is for the development of an Optimer pair to a neurodegenerative biomarker for use in an immunoassay platform. The second contract is a follow-on contract for the final stage of Optimer development to a neuronal protein target for immunohistochemistry (IHC), following positive results in the earlier stages of Optimer development. This builds on the adoption of our Optimer-Fc platform for use in automated IHC workflows."

And the last RNS of 27 Febr 24 -- "Both the lab-based research and the initial animal experiments suggest that Optimer®+ will be well placed to deliver the next generation of binders to enable the targeted delivery of precision medicines. This is an area where we are seeing increasing interest due to the unmet needs across gene therapy and precision chemotherapy."

My theory? APTA has been working flat out on this platform, Optimer + for a full year, and with this "top5 pharma partner" (AstraZeneca??) for at least 2 years, so I dare say that something will be announced on the 13th with respect to new collaborations, or scientific breakthroughs; otherwise, why ringfence scarce R&D cash to spend on Optimer+, if this existing collaboration was not close to bearing fruit?

All in my biased opinion, as usual. Good luck to LTHolders!

@FrBoy,

If I were the Mgt, I might be saving something to announce next week, to coincide with this below eg a new contract for this service;"A pre-recorded webcast from Dr David Bunka, Chief Scientific Officer of Aptamer Group, reviewing the Optimer®+ platform and the technical progress to date, will be available on the Aptamer Group website from 10:00am (UCT) on 13 March, 2024, at: https://aptamergroup.com/investors/reports-and-presentations/."

Let's also hope that there will be more traction and +ve publicity on the 13th of March, re the below:

"A pre-recorded webcast from Dr David Bunka, Chief Scientific Officer of Aptamer Group, reviewing the Optimer®+ platform and the technical progress to date, will be available on the Aptamer Group website from 10:00am (UCT) on 13 March, 2024, at: https://aptamergroup.com/investors/reports-and-presentations/."

Let's not worry about the daily volatility, we know the future is bright (blue!), we just need the Market to see 2-3 big contracts in the next month or two. It's a matter of patience now and holding our nerve until then.

BTW, SP up by about 20-25% from the bottom is not much to write home about; some people may still take profits but they may regret it, hopefully!

GLA

But no Heavy Buying either :) -- for now!

Both my BUYS this morning, one appearing as a SELL!

Anyway, not much movement expected until April unless DX project starts moving too?

Didn't they say, originally, 3mln for FY23 (ie June 2024)? They have 1.4 mln to collect on by then (for sure), plus a % of the 1.5mln (so it can be 0.5mln, 1mln or 1.5mln); plus, up to 6mln coming "longer term"; so the Shortfall might be Half to 1 million (Gross, so the net cash would be maybe half of that); so, missing out on 300k to 700k is not the end of the world, especially given that cash will last until December 2024, the Optimer+ platform will be put to the test soon (meaning higher volumes at higher margins), so this shortfall can be easily covered in the next few months.

All IMO

Thanks ARich,

If that's the case, he could consider averaging down at these ridiculous SP level; the risk-reward potential is rather worth it.

And if he gets his wish for a 0.50 Placing, then he can average down some more.

Porky,

I see what you are saying, however it is more probable (not a guarantee) that a) the SP will be higher by Dec.24 (should a raise be needed) and b) Dec 24 cash runs out IF NO OTHER SALES OCCUR UNTIL THEN.

All IMO.

Bobber is right, FY25 starts in July 24; Co mentioned in the Nov presentation that it burns 285k pm, so the 2.1mln on Jan end would suffice for 7 months (end August 24); plus some cash (say 1mln net cash) from the appx 2mln Revenues booked in H123, this extends the runway by another 3-4 months (min); therefore, Nov-Dec 24 (worst case scenario); by then, who knows what other contracts will be signed?

@Porky

When do you expect a fund raise? You said at 0.50p? And for how much?

Cash is enough until November, assuming zero income from now until then, is this a realistic assumption in your opinion?

And if the SP is 2-3 p by then, (IMO) ie a Mkt cap of 10-15mln, a cash call of 1 million (say) will have little impact on the SP.